Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Last updated: October 10, 2019
Sponsor: Central Hospital, Nancy, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Allo-hematopoietic Stem Cell Transplant

Allogeneic Hematopoietic Stem Cell Transplant

Treatment

N/A

Clinical Study ID

NCT03357172
2018-A03267-48
  • Ages > 18
  • All Genders

Study Summary

The study concerns donors and patients receiving allogeneic stem cell haematopoietic transplantation. The aim of the study is to analyse HSC graft content in immune effector T (naive, memory, activated, exhausted) and immunoregulatory cell subtypes (Tregs, iNKT, MDSC) and correlate the results with post-transplant immune reconstitution of those different cell subtypes and clinical events (graft-versus-host-disease, relapse, infections). An ancillary study will focus on the impact of microbiota dysbiosis on post-transplant immune response and regulatory cell subsets.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patient of the Nancy CHRU, for whom a CSH allograft is planned. or

  • hematopoietic stem cell donors received at Nancy's CHRU for the duration of theresearch

Exclusion

Exclusion Criteria:

  • Positive HIV

  • active hepatitis B or C infection

Study Design

Total Participants: 700
Study Start date:
October 01, 2019
Estimated Completion Date:
September 30, 2026

Connect with a study center

  • CHRU de Nancy

    Vandoeuvre Les Nancy, 54511
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.